Skip to main content
OpenTrials

Clinical trial condition

HER2 Positive Breast Carcinoma

Explore clinical trials studying HER2 Positive Breast Carcinoma. Study availability and eligibility vary by location and protocol.

18 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

HER2 Positive Breast Carcinoma trial results

Recruiting

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

NCT02945579

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +16 more
Locations
  • MD Anderson Cancer Center - Banner Gilbert, Arizona, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • Queen's Medical Center Honolulu, Hawaii, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, not recruiting

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

NCT04457596

Conditions
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +4 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
View all 1176 locations
View Trial Details
Active, not recruiting

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

NCT03384914

Conditions
Breast Cancer Female, Breast Cancer Stage I, Breast Cancer Stage II, +16 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory - Winship Cancer Institute Atlanta, Georgia, United States
  • Indiana University - Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
View Trial Details
Active, not recruiting

Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer

NCT03368729

Conditions
Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Chicago Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Montefiore The Bronx, New York, United States
View Trial Details

Related conditions